FDA will release notification rule to curb drug shortages

06/20/2013 | Health Data Management

Drugmakers will have to notify the FDA about interruptions or discontinuances in the manufacturing of life-saving treatments under a proposed rule that the agency is set to publish. The rule would mandate early notification from makers of drugs considered life-sustaining or life-supporting or that are used in the treatment or prevention of debilitating diseases.

View Full Article in:

Health Data Management

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director of Product Planning Development; Market Planning, Innovation
Blue Cross Blue Shield of Massachusetts
Quincy , MA
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX